You are here: Industry Insights > JCVI

News List

UK scientists look at reducing boosters to save vaccine for rest of the world firstwordpharma
August 23, 2021
Scientists in the UK are investigating whether smaller doses of COVID-19 vaccines could be used as part of booster programmes, stretching the supply of vaccines across the world, The Guardian reported Sunday.
JCVI ‘largely opposed’ to Covid vaccination for children under 16 firstwordpharma
August 09, 2021
Members of the UK government's expert committee on COVID-19 vaccination remain largely opposed to extending vaccination to younger adolescents, despite politicians having signalled they would like to see a shift in the guidance, The Guardian reported.
16- and 17-year-olds should receive first COVID-19 vaccine, advises JCVI pharmatimes
August 06, 2021
The Joint Committee on Vaccination and Immunisation (JCVI) has advised that all 16 and 17 year olds receive their first dose of the Pfizer-BioNTech vaccine.
New advice issued on COVID-19 vaccination of children and young people pharmatimes
July 21, 2021
The UK’s Joint Committee on Vaccination and Immunisation (JCVI) has advised that children with an increased risk of serious illness from COVID-19 should be offered the Pfizer/BioNTech vaccine.
Statement on offering COVID-19 vaccines to at-risk young people firstwordpharma
July 20, 2021
Today’s advice from the independent Joint Committee on Vaccination and Immunisation (JCVI) means more vulnerable young people at greatest risk from this virus can now benefit from COVID-19 vaccines.
British ministers decide against mass vaccination for teens - The Telegraph firstwordpharma
July 19, 2021
Britain has opted against mass COVID-19 vaccinations for all children and adolescents, with ministers instead preparing to offer vaccine doses to vulnerable 12 to 15-year-olds and those about to turn 18, as reported Financial Post.
Gap between Covid jabs to be reduced to eight weeks for all under-40s firstwordpharma
July 06, 2021
New UK health secretary Sajid Javid told lawmakers "we are reducing the dose interval [for COVID-19 vaccines] for under-40s from 12 weeks to eight," as reported in This is Money.
More pharmacies to participate in C-19 booster programme firstwordpharma
July 05, 2021
Earlier this week, the Joint Committee on Vaccination and Immunisation (JCVI) published their interim advice on COVID-19 vaccine boosters for certain cohorts of the population, including frontline health and care workers.
JCVI recommends booster COVID-19 jabs for most vulnerable groups pharmatimes
July 02, 2021
Interim advice from the Joint Committee on Vaccination and Immunisation (JCVI) recommends plans to offer COVID-19 booster vaccines to the ‘most vulnerable’ groups from September.
Letting children catch Covid may be safer than giving them vaccine, say experts firstwordpharma
July 01, 2021
A member of the UK's Joint Committee on Vaccination and Immunisation (JCVI) says allowing children to catch COVID-19 may be better than exposing them to the "risk" of vaccines, reported The Telegraph.

Previous page 1 2 Next page